Back to List View Graph View

Kaempferol

Kaempferol is a naturally occurring flavonol, specifically a 3-hydroxyflavone with a 2-phenyl-4H-chromen-4-one core, widely distributed across fruits, vegetables, and medicinal plants.

Where the papers sit

17 papers from the last 6 months study kaempferol directly · updated from PubMed 12 Nov 2026

Study type 0 clinical trials · 2 human data · 12 preclinical · 3 unclassified

Themes one subject · 1 new direction

Those 17 are all about one subject.

  • Broad Therapeutic Applications

    Mechanism-guided use of kaempferol is being explored across cancer, fibrosis, inflammation, neurodegeneration and tissue degeneration. Anticancer work repeatedly targets apoptosis, migration, β-catenin/EMT, glycolysis through AKT-mTOR, and nuclear or mitochondrial signaling. Network pharmacology and omics nominate targets such as CYP1B1, while nanoformulations, hydrogels and selenium particles aim to improve delivery and protection. The evidence remains largely preclinical, with limited clinical validation and no single disease pathway dominating.

    17 papers

NEW DIRECTION

Kaempferol is proposed as a direct inhibitor of a viral immune-evasion protein

The HSV-1 UL21 immune-evasion model studied kaempferol 3,7,4′-tri-O-β-glucoside as a candidate ligand for the viral UL21 N-terminal domain. Rather than using kaempferol within the set’s usual host-directed anticancer, anti-inflammatory, antioxidant, or tissue-protective framework, the study identifies it computationally as a scaffold that may directly disrupt UL21-mediated suppression of cGAS–STING signaling and type-I interferon responses. This extends kaempferol into direct antiviral targeting of a viral immune-evasion mechanism, although the finding remains a docking, molecular-dynamics, and energetic-profiling prediction rather than an experimentally demonstrated antiviral effect. 42748207Sep

kaempferol chemical structure

Papers

The 17 papers from the last 6 months that study kaempferol directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Broad Therapeutic Applications (17)
  1. Preparation and characterization of Kaempferol-loaded Niosomes and their effects on apoptosis and cell migration in SKOV3 ovarian cancer cells. Molecular biology reports · 25 Oct 2026 PMID 42927538
  2. CYP1B1 is a potential target of kaempferol in renal fibrosis: a multi-omics and single-cell transcriptomics study. Bioresources and bioprocessing · 20 Oct 2026 PMID 42900454
  3. Modulation of β-Catenin/EMT Axis by Croton caudatus and Its Phytoflavonoid Kaempferol Ameliorates Cervical Cancer Migration and Stemness. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 17 Oct 2026 PMID 42888968
  4. Nanoliposome-Mediated Delivery of Lipophilic Antioxidants as a Strategy to Improve the Preservation Capacity of Pig Semen at 17°C. Reproduction in domestic animals = Zuchthygiene · 1 Oct 2026 PMID 42816918
  5. Mechanistic inhibition of herpes simplex virus-1 UL21 immune-evasion function by natural-product scaffolds: A multi-tier docking, dynamics, and energetic profiling approach. PloS one · 16 Sept 2026 PMID 42748207
  6. Orchestration of kaempferol nuclear translocation by phase ii metabolic enzymes and efflux transporters suppresses colorectal cancer. PloS one · 15 Sept 2026 PMID 42743329
  7. Targeting mitochondrial dysfunction and apoptosis in 5-fluorouracil-induced cardiotoxicity using kaempferol-mediated selenium nanoparticles. Scientific reports · 12 Sept 2026 PMID 42732004
  8. Proteomic regulation of anti-proliferative and anti-migratory activity by potent phytochemicals from Pistacia integerrima J.L. Steward Ex Brandis via PI3K, AKT1, and KRAS for Lung Cancer. Molecular biology reports · 12 Sept 2026 PMID 42730982
  9. Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation. Biochemical and biophysical research communications · 11 Sept 2026 PMID 42727480
  10. Integrative single-cell profiling and explainable AI identify monocyte-metabolic signatures as diagnostic biomarkers and candidate therapeutic targets in tuberculosis. Archives of microbiology · 22 Jun 2026 PMID 42329418
  11. Exploration of the Key Mechanism by Which Kaempferol Inhibits Glycolysis in Hepatocellular Carcinoma Cells via the AKT-mTOR Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 20 Jun 2026 PMID 42322592
  12. pH-responsive in situ hydrogelation behavior of a dipotassium glycyrrhizinate-propylene glycol alginate micro-hydrogel for oral sustained release of kaempferol. Colloids and surfaces. B, Biointerfaces · 16 Jun 2026 PMID 42302545
  13. Identification of potential targets of kaempferol for the treatment of intervertebral disc degeneration based on network pharmacology and multi-omics analysis. Naunyn-Schmiedeberg's archives of pharmacology · 12 Jun 2026 PMID 42283840
  14. Evaluation of antioxidant-enriched cream formulations and their clinical effects in mild to moderate atopic dermatitis. International journal of pharmaceutics · 1 Jun 2026 PMID 42225173
  15. Dual-Responsive Polymer Nanocarriers Loaded with Active Ingredients of Tetrastigma Hemsleyanum Diels et Gilg for Targeted Therapy of Lung Cancer. Biomacromolecules · 28 May 2026 PMID 42207955
  16. Kaempferol-loaded solid lipid nanoparticles attenuate cartilage degradation and inflammation by modulating the expression of pro and inflammatory cytokines, MMP-13 and oxidative stress markers in adjuvant induced arthritic rats. Inflammopharmacology · 25 May 2026 PMID 42184086
  17. Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy. Nanoscale · 22 May 2026 PMID 42171198

By study type

Human data, design not indexed (2)
  1. Mechanistic inhibition of herpes simplex virus-1 UL21 immune-evasion function by natural-product scaffolds: A multi-tier docking, dynamics, and energetic profiling approach. PloS one · 16 Sept 2026 PMID 42748207
  2. Integrative single-cell profiling and explainable AI identify monocyte-metabolic signatures as diagnostic biomarkers and candidate therapeutic targets in tuberculosis. Archives of microbiology · 22 Jun 2026 PMID 42329418
Preclinical: animal, cell and lab studies (12)
  1. Preparation and characterization of Kaempferol-loaded Niosomes and their effects on apoptosis and cell migration in SKOV3 ovarian cancer cells. Molecular biology reports · 25 Oct 2026 PMID 42927538
  2. Modulation of β-Catenin/EMT Axis by Croton caudatus and Its Phytoflavonoid Kaempferol Ameliorates Cervical Cancer Migration and Stemness. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 17 Oct 2026 PMID 42888968
  3. Nanoliposome-Mediated Delivery of Lipophilic Antioxidants as a Strategy to Improve the Preservation Capacity of Pig Semen at 17°C. Reproduction in domestic animals = Zuchthygiene · 1 Oct 2026 PMID 42816918
  4. Orchestration of kaempferol nuclear translocation by phase ii metabolic enzymes and efflux transporters suppresses colorectal cancer. PloS one · 15 Sept 2026 PMID 42743329
  5. Targeting mitochondrial dysfunction and apoptosis in 5-fluorouracil-induced cardiotoxicity using kaempferol-mediated selenium nanoparticles. Scientific reports · 12 Sept 2026 PMID 42732004
  6. Proteomic regulation of anti-proliferative and anti-migratory activity by potent phytochemicals from Pistacia integerrima J.L. Steward Ex Brandis via PI3K, AKT1, and KRAS for Lung Cancer. Molecular biology reports · 12 Sept 2026 PMID 42730982
  7. Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation. Biochemical and biophysical research communications · 11 Sept 2026 PMID 42727480
  8. Exploration of the Key Mechanism by Which Kaempferol Inhibits Glycolysis in Hepatocellular Carcinoma Cells via the AKT-mTOR Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 20 Jun 2026 PMID 42322592
  9. pH-responsive in situ hydrogelation behavior of a dipotassium glycyrrhizinate-propylene glycol alginate micro-hydrogel for oral sustained release of kaempferol. Colloids and surfaces. B, Biointerfaces · 16 Jun 2026 PMID 42302545
  10. Evaluation of antioxidant-enriched cream formulations and their clinical effects in mild to moderate atopic dermatitis. International journal of pharmaceutics · 1 Jun 2026 PMID 42225173
  11. Dual-Responsive Polymer Nanocarriers Loaded with Active Ingredients of Tetrastigma Hemsleyanum Diels et Gilg for Targeted Therapy of Lung Cancer. Biomacromolecules · 28 May 2026 PMID 42207955
  12. Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy. Nanoscale · 22 May 2026 PMID 42171198
Unclassified: not yet indexed with MeSH (3)
  1. CYP1B1 is a potential target of kaempferol in renal fibrosis: a multi-omics and single-cell transcriptomics study. Bioresources and bioprocessing · 20 Oct 2026 PMID 42900454
  2. Identification of potential targets of kaempferol for the treatment of intervertebral disc degeneration based on network pharmacology and multi-omics analysis. Naunyn-Schmiedeberg's archives of pharmacology · 12 Jun 2026 PMID 42283840
  3. Kaempferol-loaded solid lipid nanoparticles attenuate cartilage degradation and inflammation by modulating the expression of pro and inflammatory cytokines, MMP-13 and oxidative stress markers in adjuvant induced arthritic rats. Inflammopharmacology · 25 May 2026 PMID 42184086